Stig Rödjer

2.0k total citations
63 papers, 1.2k citations indexed

About

Stig Rödjer is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Stig Rödjer has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 15 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Stig Rödjer's work include Multiple Myeloma Research and Treatments (14 papers), Cancer Treatment and Pharmacology (8 papers) and Acute Myeloid Leukemia Research (7 papers). Stig Rödjer is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Cancer Treatment and Pharmacology (8 papers) and Acute Myeloid Leukemia Research (7 papers). Stig Rödjer collaborates with scholars based in Sweden, Italy and Denmark. Stig Rödjer's co-authors include Jan Westin, Martin Hjorth, Franco Dammacco, Gianluigi Castoldi, Erik Holmberg, Bengt Magnusson, R Jagenburg, Mats Börjesson, Birgitta Swolin and Ingemar Turesson and has published in prestigious journals such as Blood, PLoS ONE and The American Journal of Medicine.

In The Last Decade

Stig Rödjer

62 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stig Rödjer Sweden 19 640 346 323 155 129 63 1.2k
John J. Stuart United States 22 266 0.4× 155 0.4× 457 1.4× 209 1.3× 137 1.1× 51 1.3k
Stanley E. Gräber United States 18 1.1k 1.8× 226 0.7× 151 0.5× 364 2.3× 60 0.5× 42 1.7k
Lawrence S. Lessin United States 25 421 0.7× 305 0.9× 630 2.0× 458 3.0× 173 1.3× 61 2.0k
Tzeon‐Jye Chiou Taiwan 17 236 0.4× 245 0.7× 254 0.8× 111 0.7× 97 0.8× 66 958
Stavroula Tsiara Greece 15 295 0.5× 249 0.7× 221 0.7× 216 1.4× 45 0.3× 38 1.0k
Gerald L. Logue United States 22 438 0.7× 127 0.4× 124 0.4× 237 1.5× 92 0.7× 53 1.1k
Peter Johan Moe Norway 22 387 0.6× 254 0.7× 209 0.6× 294 1.9× 823 6.4× 88 1.7k
Fikret Arpacı Türkiye 19 160 0.3× 267 0.8× 456 1.4× 67 0.4× 83 0.6× 74 1.1k
Núria Sala Spain 29 1.2k 1.8× 575 1.7× 426 1.3× 314 2.0× 57 0.4× 97 2.8k
H A Capell United Kingdom 25 381 0.6× 138 0.4× 195 0.6× 141 0.9× 91 0.7× 70 1.9k

Countries citing papers authored by Stig Rödjer

Since Specialization
Citations

This map shows the geographic impact of Stig Rödjer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stig Rödjer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stig Rödjer more than expected).

Fields of papers citing papers by Stig Rödjer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stig Rödjer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stig Rödjer. The network helps show where Stig Rödjer may publish in the future.

Co-authorship network of co-authors of Stig Rödjer

This figure shows the co-authorship network connecting the top 25 collaborators of Stig Rödjer. A scholar is included among the top collaborators of Stig Rödjer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stig Rödjer. Stig Rödjer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rödjer, Stig, et al.. (2014). Helicobacter pylori Antibodies and Iron Deficiency in Female Adolescents. PLoS ONE. 9(11). e113059–e113059. 12 indexed citations
2.
Rödjer, Stig, et al.. (2011). "I couldn't do this with opposition from my colleagues": A qualitative study of physicians' experiences as clinical tutors. BMC Medical Education. 11(1). 79–79. 11 indexed citations
3.
Blimark, Cecilie, Ljupco Veskovski, Jan Westin, et al.. (2011). Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation. European Journal Of Haematology. 87(2). 117–122. 12 indexed citations
4.
Hammarskjöld, Fredrik, Niklas Nielsen, Stig Rödjer, et al.. (2008). Perifert inlagd central venkateter ännu inte utvärderad för kliniskt bruk: Mer vetenskapligt stöd krävs, visar litteraturstudie. Läkartidningen. 105(21).
5.
6.
Blimark, Cecilie, et al.. (2006). Percutaneous vertebroplasty at C2: case report of a patient with multiple myeloma and a literature review. European Spine Journal. 16(S3). 242–249. 36 indexed citations
7.
Adolfsson, Peter, et al.. (2005). Iron Deficiency and Anemia: A Common Problem in Female Elite Soccer Players. International Journal of Sport Nutrition and Exercise Metabolism. 15(6). 689–694. 50 indexed citations
8.
9.
Swolin, Birgitta, et al.. (2002). Trisomies 8 and 9 not detected with fish in patients with mastocytosis. American Journal of Hematology. 70(4). 324–325. 3 indexed citations
10.
Dammacco, Franco, Gianluigi Castoldi, & Stig Rödjer. (2001). Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma. British Journal of Haematology. 113(1). 172–179. 139 indexed citations
11.
Nyhlén, Anna, et al.. (1997). Pharmacokinetics of meropenem in febrile neutropenic patients. European Journal of Clinical Microbiology & Infectious Diseases. 16(11). 797–802. 27 indexed citations
12.
Hjorth, Martin, Erik Holmberg, Stig Rödjer, Adam Taube, & Jan Westin. (1995). Patient accrual and quality of participation in a multicentre study on myeloma: a comparison between major and minor participating centres. British Journal of Haematology. 91(1). 109–115. 14 indexed citations
13.
Gustavsson, Anita, et al.. (1995). Accidental Doxorubicin Overdosage. Acta Oncologica. 34(4). 533–536. 8 indexed citations
14.
Jagenburg, R, et al.. (1993). Serum deoxythymidine kinase: no help in the diagnosis and prognosis of monoclonal gammopathy. British Journal of Haematology. 84(4). 746–748. 4 indexed citations
15.
Back, H., Göran Nilsson, Göran K. Hansson, Stig Rödjer, & Andrzej Tarkowski. (1991). M-component with reactivity against actin associated with thrombotic thrombocytopenic purpura. The American Journal of Medicine. 91(4). 429–433. 4 indexed citations
16.
Hjorth, Martin, et al.. (1990). Initial treatment in multiple myeloma: no advantage of multidrug chemotherapy over melphalan‐prednisone. British Journal of Haematology. 74(2). 185–191. 40 indexed citations
17.
Rödjer, Stig, Olle Vikrot, Anders Wåhlin, & Jan Westin. (1990). Effect of interferon alpha‐2b in advanced multiple myeloma. Journal of Internal Medicine. 227(1). 45–48. 4 indexed citations
18.
Swolin, Birgitta, Stig Rödjer, & Jan Westin. (1990). Bone marrow in vitro growth and cytogenetic studies in patients with fab‐classified primary myelodysplastic syndromes. American Journal of Hematology. 34(3). 175–180. 11 indexed citations
19.
Hasselbalch, Hans Carl, Ida Maria Lisse, Birgitta Swolin, et al.. (1988). Recombinant interferon‐alpha‐2b treatment of hairy‐cell leukaemia: Experience with a low‐dose schedule. European Journal Of Haematology. 41(5). 438–444. 15 indexed citations
20.
Jagenburg, R, et al.. (1972). Hereditary tyrosinemia: Metabolic studies in a patient with partial p-hydroxyphenylpyruvate hydroxylase activity. The Journal of Pediatrics. 80(6). 994–1004. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John J. Stuart Breakdown of academic impact, for papers by Stanley E. Gräber Breakdown of academic impact, for papers by Lawrence S. Lessin Breakdown of academic impact, for papers by Tzeon‐Jye Chiou Breakdown of academic impact, for papers by Stavroula Tsiara Breakdown of academic impact, for papers by Gerald L. Logue Breakdown of academic impact, for papers by Peter Johan Moe Breakdown of academic impact, for papers by Fikret Arpacı Breakdown of academic impact, for papers by Núria Sala Breakdown of academic impact, for papers by H A Capell
Rankless by CCL
2026